m+Medelevator.RU
← Поиск публикаций
Journal of cataract and refractive surgery · 2014

Eighteen-year follow-up of excimer laser photorefractive keratectomy.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Shalchi Zaid, O'Brart David P S, McDonald Robert J, Patel Parul, Archer Timothy J, Marshall John

Аннотация

PURPOSE: To evaluate the long-term efficacy of photorefractive keratectomy (PRK).

SETTING: University Hospital, London, United Kingdom.

DESIGN: Prospective case series.

METHODS: One eye of patients who had PRK 18 years previously was examined. All had myopic corrections with a 6.0 mm optical zone.

RESULTS: Forty-six patients were examined. The mean preoperative spherical equivalent (SE) refractive error was -4.86 diopters (D) (range -2.75 to -7.375 D). The mean programmed correction was -4.43 D (range -2.50 to -7.00 D). Between 1 year and 18 years, the mean change in SE was -0.31 D (P = .06) and a significant increase in variance occurred (P < .002). The mean change in SE was -0.54 D in patients younger than 40 years at the time of correction (P < .02) and -0.05 D in patients older than 40 years (P = .9). The mean SE change was -0.40 D in women (P < .04) and -0.08 D in men (P = .8). The efficacy index was 0.58. The safety index was 0.998. The corrected distance visual acuity (CDVA) improved significantly from 1 to 18 years (P < .01). Ninety-six percent of corneas were clear at 18 years, with a reduction in haze scores (P < .001). There was no evidence of ectasia.

CONCLUSIONS: A significant increase in myopic SE occurred between 1 year and 18 years after PRK in patients younger than 40 years and in women. Predictability decreased between 1 year and 18 years. The procedure was safe with no long-term complications. The CDVA and corneal transparency improved with time.

FINANCIAL DISCLOSURE: Dr. Marshall was a consultant to Summit Technology, Inc. No author has a financial or proprietary interest in any material or method mentioned.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты